Publications by authors named "Monique Bedin"

Claim this Profile
L
Ligand-free estrogen receptor activity complements IGF1R to induce the proliferation of the MCF-7 breast cancer cells.
Anne-Marie Gaben, Michèle Sabbah, Gérard Redeuilh, Monique Bedin, Jan Mester

BMC Cancer· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indirect participation of Hsp90 in the regulation of the cyclin E turnover.
Monique Bedin, Maria-Grazia Catelli, Lucien Cabanié, Anne-Marie Gaben, Jan Mester

Biochem Pharmacol· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitogenic activity of estrogens in human breast cancer cells does not rely on direct induction of mitogen-activated protein kinase/extracellularly regulated kinase or phosphatidylinositol 3-kinase.
Anne-Marie Gaben, Cécile Saucier, Monique Bedin, Gérard Redeuilh, Jan Mester

Mol Endocrinol· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Geldanamycin, an inhibitor of the chaperone activity of HSP90, induces MAPK-independent cell cycle arrest.
Monique Bedin, Anne-Marie Gaben, Cécile Saucier, Jan Mester

Int J Cancer· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapamycin inhibits cdk4 activation, p 21(WAF1/CIP1) expression and G1-phase progression in transformed mouse fibroblasts.
Anne-Marie Gaben, Cecile Saucier, Monique Bedin, Véronique Barbu, Jan Mester

Int J Cancer· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The c-kit tyrosine kinase inhibitor STI571 for colorectal cancer therapy.
Samir Attoub, Christine Rivat, Sylvie Rodrigues, Saskia Van Bocxlaer, Monique Bedin

Cancer Res· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis